Clinical Factors for Prognosis and Treatment Guidance of Spinal Cord Astrocytoma

Study DesignRetrospective study.PurposeTo obtain information useful in establishing treatment guidelines by evaluating baseline clinical features and treatment outcomes of patients with spinal cord astrocytoma (SCA).Overview of LiteratureThe optimal management of SCA remains controversial, and there...

Full description

Bibliographic Details
Main Authors: Toshitaka Seki, Kazutoshi Hida, Shunsuke Yano, Takeshi Aoyama, Izumi Koyanagi, Toru Sasamori, Shuji Hamauch, Kiyohiro Houkin
Format: Article
Language:English
Published: Korean Spine Society 2016-08-01
Series:Asian Spine Journal
Subjects:
Online Access:http://www.asianspinejournal.org/upload/pdf/asj-10-748.pdf
id doaj-e868bc3e90034fc1ab8892665d57585f
record_format Article
spelling doaj-e868bc3e90034fc1ab8892665d57585f2020-11-25T00:13:42ZengKorean Spine SocietyAsian Spine Journal1976-19021976-78462016-08-0110474875410.4184/asj.2016.10.4.748147Clinical Factors for Prognosis and Treatment Guidance of Spinal Cord AstrocytomaToshitaka Seki0Kazutoshi Hida1Shunsuke Yano2Takeshi Aoyama3Izumi Koyanagi4Toru Sasamori5Shuji Hamauch6Kiyohiro Houkin7Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.Department of Neurosurgery, Sapporo Azabu Neurosurgical Hospital, Sapporo, Japan.Department of Neurosurgery, Sapporo Azabu Neurosurgical Hospital, Sapporo, Japan.Department of Orthopedic Surgery, Teine Keijinkai Hospital, Sapporo, Japan.Department of Neurosurgery, Hokkaido Neurosurgical Memorial Hospital, Sapporo, Japan.Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.Study DesignRetrospective study.PurposeTo obtain information useful in establishing treatment guidelines by evaluating baseline clinical features and treatment outcomes of patients with spinal cord astrocytoma (SCA).Overview of LiteratureThe optimal management of SCA remains controversial, and there are no standard guidelines.MethodsThe study included 20 patients with low-grade and 13 with high-grade SCA surgically treated between 1989 and 2014. Patients were classified according to the extent of surgical resection. Survival was assessed using Kaplan–Meier plots and compared between groups by log-rank tests. Neurological status was defined by the modified McCormick scale and compared between groups by Mann–Whitney U tests.ResultsSurgical resection was performed for 19 of 20 low-grade (95%) and 10 of 13 high-grade (76.9%) SCA patients. Only nine patients (27.3%) underwent gross total resection, all of whom had low-grade SCA. Of all patients, 51.5% showed deteriorated neurological status compared to preoperative baseline. Median overall survival was significantly longer for low-grade SCA than that (91 months, 78% at 5 years vs. 15 months, 31% at 5 years; p=0.007). Low-grade SCA patients benefited from more aggressive resection, whereas high-grade SCA patients did not. Multivariate analysis revealed histology status (hazard ratio [HR], 0.30; 95% confidence interval [CI], 0.09–0.98; p<0.05) and postoperative neurological status (HR, 0.12; CI, 0.02–0.95; p<0.05) as independent predictors of longer overall survival. Adjuvant radiotherapy had no significant impact on survival rate. However, a trend for increased survival was observed with radiation cordotomy (RCT) in high-grade SCA patients.ConclusionsAggressive resection for low-grade and RCT may prolong survival. Preservation of neurological status is an important treatment goal. Given the low incidence of SCA, establishing strong collaborative, interdisciplinary, and multi-institutional study groups is necessary to define optimal treatments.http://www.asianspinejournal.org/upload/pdf/asj-10-748.pdfAstrocytomaIntramedullary tumorOutcomeRadiotherapySurgery
collection DOAJ
language English
format Article
sources DOAJ
author Toshitaka Seki
Kazutoshi Hida
Shunsuke Yano
Takeshi Aoyama
Izumi Koyanagi
Toru Sasamori
Shuji Hamauch
Kiyohiro Houkin
spellingShingle Toshitaka Seki
Kazutoshi Hida
Shunsuke Yano
Takeshi Aoyama
Izumi Koyanagi
Toru Sasamori
Shuji Hamauch
Kiyohiro Houkin
Clinical Factors for Prognosis and Treatment Guidance of Spinal Cord Astrocytoma
Asian Spine Journal
Astrocytoma
Intramedullary tumor
Outcome
Radiotherapy
Surgery
author_facet Toshitaka Seki
Kazutoshi Hida
Shunsuke Yano
Takeshi Aoyama
Izumi Koyanagi
Toru Sasamori
Shuji Hamauch
Kiyohiro Houkin
author_sort Toshitaka Seki
title Clinical Factors for Prognosis and Treatment Guidance of Spinal Cord Astrocytoma
title_short Clinical Factors for Prognosis and Treatment Guidance of Spinal Cord Astrocytoma
title_full Clinical Factors for Prognosis and Treatment Guidance of Spinal Cord Astrocytoma
title_fullStr Clinical Factors for Prognosis and Treatment Guidance of Spinal Cord Astrocytoma
title_full_unstemmed Clinical Factors for Prognosis and Treatment Guidance of Spinal Cord Astrocytoma
title_sort clinical factors for prognosis and treatment guidance of spinal cord astrocytoma
publisher Korean Spine Society
series Asian Spine Journal
issn 1976-1902
1976-7846
publishDate 2016-08-01
description Study DesignRetrospective study.PurposeTo obtain information useful in establishing treatment guidelines by evaluating baseline clinical features and treatment outcomes of patients with spinal cord astrocytoma (SCA).Overview of LiteratureThe optimal management of SCA remains controversial, and there are no standard guidelines.MethodsThe study included 20 patients with low-grade and 13 with high-grade SCA surgically treated between 1989 and 2014. Patients were classified according to the extent of surgical resection. Survival was assessed using Kaplan–Meier plots and compared between groups by log-rank tests. Neurological status was defined by the modified McCormick scale and compared between groups by Mann–Whitney U tests.ResultsSurgical resection was performed for 19 of 20 low-grade (95%) and 10 of 13 high-grade (76.9%) SCA patients. Only nine patients (27.3%) underwent gross total resection, all of whom had low-grade SCA. Of all patients, 51.5% showed deteriorated neurological status compared to preoperative baseline. Median overall survival was significantly longer for low-grade SCA than that (91 months, 78% at 5 years vs. 15 months, 31% at 5 years; p=0.007). Low-grade SCA patients benefited from more aggressive resection, whereas high-grade SCA patients did not. Multivariate analysis revealed histology status (hazard ratio [HR], 0.30; 95% confidence interval [CI], 0.09–0.98; p<0.05) and postoperative neurological status (HR, 0.12; CI, 0.02–0.95; p<0.05) as independent predictors of longer overall survival. Adjuvant radiotherapy had no significant impact on survival rate. However, a trend for increased survival was observed with radiation cordotomy (RCT) in high-grade SCA patients.ConclusionsAggressive resection for low-grade and RCT may prolong survival. Preservation of neurological status is an important treatment goal. Given the low incidence of SCA, establishing strong collaborative, interdisciplinary, and multi-institutional study groups is necessary to define optimal treatments.
topic Astrocytoma
Intramedullary tumor
Outcome
Radiotherapy
Surgery
url http://www.asianspinejournal.org/upload/pdf/asj-10-748.pdf
work_keys_str_mv AT toshitakaseki clinicalfactorsforprognosisandtreatmentguidanceofspinalcordastrocytoma
AT kazutoshihida clinicalfactorsforprognosisandtreatmentguidanceofspinalcordastrocytoma
AT shunsukeyano clinicalfactorsforprognosisandtreatmentguidanceofspinalcordastrocytoma
AT takeshiaoyama clinicalfactorsforprognosisandtreatmentguidanceofspinalcordastrocytoma
AT izumikoyanagi clinicalfactorsforprognosisandtreatmentguidanceofspinalcordastrocytoma
AT torusasamori clinicalfactorsforprognosisandtreatmentguidanceofspinalcordastrocytoma
AT shujihamauch clinicalfactorsforprognosisandtreatmentguidanceofspinalcordastrocytoma
AT kiyohirohoukin clinicalfactorsforprognosisandtreatmentguidanceofspinalcordastrocytoma
_version_ 1725393522441322496